中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Negative CT Contrast Agents for the Diagnosis of Malignant Osteosarcoma

文献类型:期刊论文

作者Meng, Xianfu; Zhang, Hua; Zhang, Meng; Wang, Baoming; Liu, Yanyan; Wang, Yan; Fang, Xiangming; Zhang, Jiawen; Yao, Zhenwei; Bu, Wenbo
刊名ADVANCED SCIENCE
出版日期2019-12-31
关键词H-2 release HMSN@AB@PEG negative CT contrast agents osteosarcoma tumor acidic microenvironment
DOI10.1002/advs.201901214
文献子类Article; Early Access
英文摘要The current positive computed tomography (CT) contrast agents (PCTCAs) including clinical iodides, present high CT density value (CT-DV). However, they are incapable for the accurate diagnosis of some diseases with high CT-DV, such as osteosarcoma. Because bones and PCTCAs around osteosarcoma generate similar X-ray attenuations. Here, an innovative strategy of negative CT contrast agents (NCTCAs) to reduce the CT-DV of osteosarcoma is proposed, contributing to accurate detection of osteosarcoma. Hollow mesoporous silica nanoparticles, loading ammonia borane molecules and further modified by polyethylene glycol, are synthesized as NCTCAs for the diagnosis of osteosarcoma. The nanocomposites can produce H-2 in situ at osteosarcoma areas by responding to the acidic microenvironment of osteosarcoma, resulting in nearly 20 times reduction of CT density in osteosarcoma. This helps form large CT density contrast between bones and osteosarcoma, and successfully achieves accurate diagnosis of osteosarcoma. Meanwhile, The NCTCAs strategy greatly expands the scope of CT application, and provides profound implications for the precise clinical diagnosis, treatment, and prognosis of diseases.
WOS关键词NERVOUS-SYSTEM LYMPHOMA ; AMMONIA-BORANE ; UP-CONVERSION ; HEART-DISEASE ; IN-VIVO ; TUMOR ; ANGIOGRAPHY ; DEHYDROGENATION ; LUMINESCENCE ; PERFORMANCE
WOS研究方向Chemistry ; Science & Technology - Other Topics ; Materials Science
语种英语
出版者WILEY
源URL[http://ir.sic.ac.cn/handle/331005/27526]  
专题中国科学院上海硅酸盐研究所
推荐引用方式
GB/T 7714
Meng, Xianfu,Zhang, Hua,Zhang, Meng,et al. Negative CT Contrast Agents for the Diagnosis of Malignant Osteosarcoma[J]. ADVANCED SCIENCE,2019.
APA Meng, Xianfu.,Zhang, Hua.,Zhang, Meng.,Wang, Baoming.,Liu, Yanyan.,...&Bu, Wenbo.(2019).Negative CT Contrast Agents for the Diagnosis of Malignant Osteosarcoma.ADVANCED SCIENCE.
MLA Meng, Xianfu,et al."Negative CT Contrast Agents for the Diagnosis of Malignant Osteosarcoma".ADVANCED SCIENCE (2019).

入库方式: OAI收割

来源:上海硅酸盐研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。